论文部分内容阅读
●CRISPR-Cas9专利引发的一场争战,凸显了一个不得不引起重视的问题:过度追求技术商业化,对科研事业的发展是有害的。不久前,在美国专利商标局,大学聘请的律师代表其客户提出了CRISPR-Cas9基因编辑技术专利所有权归属问题诉讼,一场吸引眼球的专利权争战开始打响。美国专利商标局会在未来的一年里,收集大量证据来证明,究竟是谁第一个发明了这项技术。科学上的优先权之战和科学发展本身一样古老。
● A battle triggered by the CRISPR-Cas9 patent highlights a problem that has to be emphasized: Over-pursuing technological commercialization is detrimental to the development of scientific research. Not long ago, at the USPTO, a lawyer hired by the University filed a lawsuit on the ownership of the CRISPR-Cas9 gene editing technology patent on behalf of his client, and a spectacular patent battle started. The United States Patent and Trademark Office in the coming year, to collect a lot of evidence to prove that, after all, who invented the technology first. The battle for scientific priority is just as old as scientific development itself.